{
    "title": "107_hr2172",
    "content": "The \"Cloning Prohibition Act of 2001\" prohibits human cloning under the Federal Food, Drug, and Cosmetic Act by adding a new chapter on human cloning. The \"Cloning Prohibition Act of 2001\" prohibits human cloning by banning the use of human somatic cell nuclear transfer technology to initiate a pregnancy or transport resulting cellular products for that purpose. This technology involves transferring a human somatic cell nucleus into an egg cell. The \"Cloning Prohibition Act of 2001\" prohibits human cloning through various technologies, including somatic cell nuclear transfer, gene therapy, in vitro fertilization, and cloning animals. Registration is required for individuals intending to perform human somatic cell nuclear transfer technology. Individuals intending to perform human somatic cell nuclear transfer technology must register with the Secretary, providing their name, place of business, and additional information as required. Registration must include a statement declaring awareness of the technology. The registration for human somatic cell nuclear transfer technology requires individuals to declare awareness of prohibitions and confidentiality measures. This section preempts any conflicting state laws. The Cloning Prohibition Act of 2001 prohibits certain research practices related to somatic cell nuclear transfer, mitochondrial therapy, and cloning of molecules, DNA, cells, tissues, or organs. State or local laws existing before the enactment of the Act are exempt. The Act has a sunset provision after 10 years and does not establish a private right of action. The Cloning Prohibition Act of 2001 prohibits specific research practices related to cloning and imposes criminal and civil penalties for violations. The Cloning Prohibition Act of 2001 imposes civil penalties for violations, with fines up to $1,000,000 or double the gross pecuniary gain from the violation. Additionally, property derived from or used in violation of the Act can be forfeited. Violators of section 301(bb) may face forfeiture of property to the United States. SEC. 3. STUDY BY INSTITUTE OF MEDICINE. The Secretary of Health and Human Services requests the Institute of Medicine to conduct a study on the biological properties of stem cells from embryos, fetal tissues, and adult tissues, including their differences and potential clinical uses. The Secretary will request the Institute of Medicine to study stem cells from various sources. If the Institute declines, another entity will be chosen. A report on the study's findings must be submitted to specific committees within three years."
}